Bangi Inc. (BNGI) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBangi Inc. (BNGI) trades at $0.00001. Bangi Inc. operates within the cannabis industry, acquiring and leasing specialized real estate assets. The company's portfolio includes hemp and cannabis farms, dispensaries, and commercial properties. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for BNGI: BNGI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BNGI against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
BNGI: the 2 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Bangi Inc. (BNGI) Healthcare & Pipeline Overview
Bangi Inc. focuses on acquiring and leasing specialized real estate assets within the cannabis industry, including hemp farms, dispensaries, and commercial properties. As a subsidiary of Bangi Investments, LLC, the company operates in a dynamic sector influenced by evolving regulations and market demand for cannabis-related businesses.
What Is the Investment Thesis for BNGI?
Bangi Inc. presents a speculative investment opportunity within the cannabis industry's real estate sector. The company's focus on acquiring and leasing specialized properties to cannabis businesses offers exposure to the industry's growth potential. However, the company's small market capitalization ($0.00B) and negative P/E ratio (-0.00) indicate significant financial risks. The company's beta of -36.90 suggests high volatility and a negative correlation with the market. Growth catalysts include the continued legalization of cannabis in new markets and the expansion of existing cannabis businesses. However, potential risks include regulatory changes, competition from larger real estate companies, and the overall volatility of the cannabis market. Investors should carefully consider these factors before investing in Bangi Inc.
Based on FMP financials and quantitative analysis
BNGI Key Highlights
Bangi Inc. operates as a subsidiary of Bangi Investments, LLC, indicating a potential source of capital and strategic direction.
- The company's focus on specialized real estate assets within the cannabis industry provides a niche market position.
- Bangi Inc. has a market capitalization of $0.00B, reflecting its small size and potential for high volatility.
- The company's negative P/E ratio of -0.00 suggests it is currently not profitable.
- Bangi Inc. has a beta of -36.90, indicating a negative correlation with the market and high volatility.
Who Are BNGI's Competitors?
BNGI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| RLYB Rallybio Corporation | $16.75 | -1.30% | $88.9M | 825-pillar |
| ICCC ImmuCell Corporation | $9.91 | +0.05% | $89.7M | 775-pillar |
| ORMP Oramed Pharmaceuticals Inc. | $4.74 | -0.38% | $194M | 785-pillar |
| NAGE Niagen Bioscience Inc | $3.04 | -0.49% | $242M | 665-pillar |
| QTTB Q32 Bio Inc. | $10.93 | +1.96% | $325M | 685-pillar |
| NWPHF Newron Pharmaceuticals S.p.A. | $20.00 | 0.00% | $416M | 689-signal |
| CRMD CorMedix Inc. | $7.96 | -0.06% | $624M | 885-pillar |
| MDXG MiMedx Group, Inc. | $4.60 | -1.71% | $671M | 875-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BNGI's Key Strengths?
Focus on a niche market within the cannabis industry.
- Potential for high growth in a rapidly expanding sector.
- Established relationships with cannabis businesses.
- Real estate portfolio tailored to the specific needs of cannabis companies.
What Are BNGI's Weaknesses?
Small market capitalization and limited financial resources.
- Dependence on the regulatory environment of the cannabis industry.
- Competition from larger real estate companies.
- Lack of diversification in real estate assets.
What Could Drive BNGI Stock Higher?
BNGI catalyst: Continued legalization of cannabis in new markets, expanding the potential customer base for Bangi Inc.'s real estate services.
- Growth of the cannabis industry, increasing demand for specialized real estate assets.
- Potential acquisitions of new properties to expand Bangi Inc.'s real estate portfolio. (Timeline: Unknown)
- Strategic partnerships with cannabis businesses to develop customized real estate solutions. (Timeline: Unknown)
What Are the Key Risks for BNGI?
Changes in cannabis regulations that could negatively impact the industry and reduce demand for Bangi Inc.'s services.
- Increased competition from larger real estate companies with greater resources.
- Economic downturns that could reduce demand for cannabis products and negatively impact Bangi Inc.'s tenants.
- Negative public perception of the cannabis industry that could affect Bangi Inc.'s reputation and business.
What Are the Growth Opportunities for BNGI?
- Expansion into New Geographic Markets: As cannabis legalization expands across different states and countries, Bangi Inc. has the opportunity to expand its real estate portfolio into new geographic markets. This expansion could involve acquiring properties in emerging cannabis markets and leasing them to cannabis businesses.
- Diversification of Real Estate Assets: Bangi Inc. can diversify its real estate portfolio by acquiring different types of properties, such as cultivation facilities, processing plants, and retail dispensaries. This diversification would reduce the company's reliance on any single type of property and mitigate risks associated with changes in market demand. The market for specialized cannabis real estate is expected to grow as the industry matures. Timeline: Ongoing.
- Strategic Partnerships with Cannabis Businesses: Bangi Inc. can form strategic partnerships with cannabis businesses to provide them with customized real estate solutions. These partnerships could involve developing new properties tailored to the specific needs of cannabis companies. The market for customized cannabis real estate is growing as cannabis businesses seek to optimize their operations. Timeline: Ongoing.
- Investment in Technology and Innovation: Bangi Inc. can invest in technology and innovation to improve the efficiency and sustainability of its real estate assets. This could involve implementing energy-efficient systems, water conservation technologies, and advanced security measures. The market for sustainable cannabis real estate is growing as cannabis businesses seek to reduce their environmental impact. Timeline: Ongoing.
- Acquisition of Competitors: Bangi Inc. can acquire smaller competitors to expand its market share and geographic reach. This consolidation strategy would allow the company to leverage its existing infrastructure and expertise to grow its business. The cannabis real estate market is fragmented, providing opportunities for consolidation. Timeline: Ongoing.
What Are BNGI's Competitive Advantages?
- Specialized real estate expertise within the cannabis industry.
- Established relationships with cannabis businesses.
- Portfolio of properties tailored to the specific needs of cannabis companies.
What Does BNGI Do?
Bangi Inc., based in Grosse Pointe Farms, Michigan, specializes in the acquisition and leasing of real estate assets tailored to the cannabis industry. The company's portfolio encompasses a range of properties, including hemp and cannabis farms, dispensaries, and commercial and industrial real estate. As a subsidiary of Bangi Investments, LLC, Bangi Inc. operates within a rapidly evolving sector, providing essential infrastructure to cannabis businesses. The company's business model centers on identifying and acquiring properties suitable for cannabis cultivation, processing, distribution, and retail. By leasing these specialized assets, Bangi Inc. enables cannabis companies to focus on their core operations while relying on Bangi Inc. for their real estate needs. This approach allows Bangi Inc. to capitalize on the growth of the cannabis industry without directly engaging in cannabis production or sales. The company's success is closely tied to the regulatory landscape and the increasing acceptance and legalization of cannabis across various jurisdictions. Bangi Inc. faces competition from other real estate companies and investors also targeting the cannabis sector.
What Products and Services Does BNGI Offer?
- Acquires specialized real estate assets tailored to the cannabis industry.
- Leases properties to cannabis businesses, including farms, dispensaries, and commercial spaces.
- Provides real estate solutions for cannabis cultivation, processing, distribution, and retail.
- Operates as a subsidiary of Bangi Investments, LLC.
- Focuses on identifying and acquiring properties suitable for cannabis-related activities.
- Enables cannabis companies to focus on their core operations by providing real estate infrastructure.
How Does BNGI Make Money?
- Acquires real estate assets suitable for cannabis-related activities.
- Leases these properties to cannabis businesses for cultivation, processing, distribution, and retail.
- Generates revenue through rental income from leased properties.
What Industry Does BNGI Operate In?
Bangi Inc. operates within the rapidly growing cannabis industry, which is experiencing increasing legalization and acceptance across various jurisdictions. The industry encompasses a wide range of businesses, including cannabis cultivation, processing, distribution, and retail. Bangi Inc. focuses on providing real estate solutions to these businesses, capitalizing on the demand for specialized properties. The competitive landscape includes other real estate companies and investors targeting the cannabis sector. The industry is subject to evolving regulations and market dynamics, which can significantly impact Bangi Inc.'s business.
Who Are BNGI's Key Customers?
- Cannabis cultivators requiring land and facilities for growing cannabis.
- Cannabis processors needing facilities for extracting and refining cannabis products.
- Cannabis dispensaries seeking retail spaces to sell cannabis products to consumers.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 50 |
| 2026-08-26 | 50 |
| 2026-08-29 | 50 |
| 2026-09-01 | 50 |
| 2026-09-04 | 50 |
| 2026-09-07 | 50 |
| 2026-09-10 | 50 |
What changed?
The score has stayed at 50.
Over the same 18 days the stock moved +0.0%.
Company Profile
Bangi Inc. operates in the Real Estate - Services industry within the Real Estate sector. It is headquartered in Grosse Pointe Farms, US. The company is led by CEO Nicole Birch. BNGI has traded publicly since 2006.
BNGI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Focus on a niche market within the cannabis industry.
- Potential for high growth in a rapidly expanding sector.
- Established relationships with cannabis businesses.
- Real estate portfolio tailored to the specific needs of cannabis companies.
Bear Case
- Small market capitalization and limited financial resources.
- Dependence on the regulatory environment of the cannabis industry.
- Competition from larger real estate companies.
- Lack of diversification in real estate assets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
BNGI Latest News
-
SEC Suspends Trading In 15 Stocks Over Social Media Concerns
· Feb 27, 2021
-
Stocks That Hit 52-Week Lows On Monday
· Jan 27, 2020
BNGI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BNGI.
Price Targets
Wall Street price target analysis for BNGI.
BNGI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BNGI; grades run from A+ (80-100) to F (below 30).
Leadership: Nicole Birch
Managing
Nicole Birch currently manages Bangi Inc. with a team of 4 employees. As the head of the company, she is responsible for overseeing the company's operations and strategic direction within the cannabis real estate sector.
Track Record: Due to limited information available, Nicole Birch's specific achievements and strategic decisions at Bangi Inc. cannot be determined. The company's performance and milestones under her leadership are currently unknown.
BNGI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bangi Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks. Investing in companies on the OTC Other tier requires a higher degree of due diligence and risk tolerance compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited information and disclosure requirements compared to major exchanges.
- Higher risk of fraud and manipulation due to less regulatory oversight.
- Low liquidity and wide bid-ask spreads, making it difficult to buy or sell shares.
- Greater price volatility due to limited trading volume.
- Potential for delisting or suspension of trading.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price activity.
- Consult with a financial advisor before investing.
- Company is a subsidiary of Bangi Investments, LLC.
- Focus on a specific niche within the cannabis industry.
- Company has been in operation for several years.
- Company has a website and contact information.
Common Questions About BNGI (Healthcare)
Is BNGI a good stock?
Stock Expert AI does not rate BNGI buy, sell or hold. Bangi Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about BNGI stock?
Currently, there is no available analyst coverage or consensus on Bangi Inc. (BNGI) stock. The company's small market capitalization and OTC listing may contribute to the lack of analyst attention.
What are the key factors to evaluate for BNGI?
Evaluate BNGI on fundamentals, analyst consensus, and risk factors. The company's beta of -36.90 suggests high volatility and a negative correlation with the market. Not financial advice.
How frequently does BNGI data refresh on this page?
BNGI's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BNGI's recent stock price performance?
Bangi Inc. (BNGI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a niche market within the cannabis industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BNGI overvalued or undervalued right now?
Bangi Inc. (BNGI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BNGI?
Yes, most major brokerages offer fractional shares of Bangi Inc. (BNGI) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BNGI's earnings and financial reports?
Bangi Inc. (BNGI) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BNGI earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Bangi Inc. due to its OTC listing and small market capitalization.
- Financial data is limited, making it difficult to assess the company's performance and prospects.
- The cannabis industry is subject to evolving regulations and market dynamics, which can significantly impact Bangi Inc.'s business.